Antiretroviral Agents in HIV-1

Antiretroviral Agents in HIV

DHHS HIV GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/65244

Contents of this Issue

Navigation

Page 11 of 25

Selecting a Treatment Regimen Table 5A. Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Drug Lamivudine (3TC) Epivir® 3TC/ZDV Combivir® 3TC/ABC Epzicom® 3TC/ZDV/ABC Trizivir® Stavudine (d4T) Zerit® Generic Formulation 150, 300 mg tablets or 10 mg/mL oral solution Dosing Recommendations 150 mg bid or 300 mg once daily ▶ Take without regard to meals 3TC 150 mg + ZDV 300 mg 1 tablet bid 3TC 300 mg + ABC 600 mg 1 tablet once daily 1 tablet bid 3TC 150 mg + ZDV 300 mg + ABC 300 mg 15, 20, 30, 40 mg capsules or 1 mg/mL oral solution Body weight ≥ 60 kg: 40 mg bid Body weight < 60 kg: 30 mg bid b ▶ Take without regard to meals b WHO recommends 30 mg bid dosing regardless of body weight Tenofovir Disoproxil Fumarate (TDF) Viread® 150, 200, 250, 300 mg tablets or 40 mg/1 gm oral powder Adults: 300 mg once daily Children ≥ 2 years: ≥ 17 kg: tablets based on body weight (see PI) or oral powdera 8 mg/kg once daily Max: 300 mg/d < 17 kg: oral powdera once daily Max: 300 mg/d FTC/TDF/EFV Atripla® FTC/TDF/RPV Complera™ FTC/TDF Truvada® Zidovudine (AZT, ZDV) Retrovir® Generic 3TC/ ZDV Combivir® 3TC/ABC/ZDV Trizivir® 10 FTC 200 mg + TDF 300 mg + EFV 600 mg FTC 200 mg + TDF 300 mg + RPV 25 mg 100 mg capsules, 300 mg tablets, 10 mg/mL intravenous solution, 10 mg/mL oral solution 3TC 150 mg + ABC 300 mg + ZDV 300 mg a Oral powder should be taken with food 8 mg/kg 1 tablet at or before bedtime ▶ Take on an empty stomach to reduce side effects One tablet once daily with meal FTC 200 mg + TDF 300 mg 1 tablet once daily 300 mg bid or 200 mg tid ▶ Take without regard to meals 3TC 150 mg + ZVD 300 mg 1 tablet bid 1 tablet bid Also available in: Also available in: Also available in:

Articles in this issue

Archives of this issue

view archives of Antiretroviral Agents in HIV-1 - Antiretroviral Agents in HIV